MOTS-C Research:
Mitochondrial Peptide & Metabolic Regulation
MOTS-C is a mitochondria-derived peptide encoded in the mitochondrial 12S rRNA. It translocates to the nucleus to regulate AMPK signaling, glucose homeostasis, and skeletal muscle metabolism — a unique mitochondrial-nuclear signaling axis.
What Is MOTS-C?
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid mitochondria-derived peptide encoded by a short open reading frame (sORF) within the mitochondrial 12S ribosomal RNA. First characterized in 2015 by Lee et al., MOTS-C belongs to the emerging class of mitochondrial-derived peptides (MDPs) that function as inter-organelle and systemic signaling molecules — distinct from nuclear-encoded mitochondrial proteins.
MOTS-C translocates from mitochondria to the cytoplasm and nucleus in response to metabolic stress, where it regulates AMPK, folate-methionine metabolism, and glucose utilization in skeletal muscle. It is a valuable research tool for metabolic disease models, longevity biology, and mitochondrial signaling research. Lumen Peppers provides research-grade MOTS-C for in vitro and preclinical laboratory use only.
Key Research Findings
MOTS-C research spans metabolic regulation, insulin sensitivity, aging biology, and mitochondrial signaling in skeletal muscle and beyond.
AMPK Activation in Skeletal Muscle
MOTS-C activates AMPK in skeletal muscle cells, increasing glucose uptake via GLUT4 translocation to the plasma membrane. In HFD (high-fat diet) mouse models, MOTS-C injection reduces adiposity, improves insulin sensitivity, and increases aerobic capacity without caloric restriction.
Folate-Methionine Cycle Modulation
MOTS-C inhibits the folate cycle enzyme AICAR transformylase (ATIC), causing accumulation of the AMPK-activating metabolite ZMP (AICAR monophosphate). This mitochondrial-to-nuclear signaling cascade links mitochondrial metabolic state to nuclear gene regulation through a novel metabolite relay.
Exercise Mimetic Research
Exogenous MOTS-C administration in aged mice restores exercise capacity comparable to younger mice. It increases PGC-1α expression, mitochondrial biogenesis, and fatty acid oxidation in muscle — making it a valuable research tool for studying exercise biology and age-related metabolic decline.
Longevity & Aging Biology
Circulating MOTS-C levels decline with age in both mice and humans. Supplementation in aged rodent models improves metabolic flexibility, reduces inflammatory markers, and extends healthspan in some models. MOTS-C is used in aging research as a mitochondrial health biomarker and intervention tool.
Anti-Inflammatory & Stress Response
MOTS-C translocates to the nucleus under stress conditions and activates the Nrf2 antioxidant response element (ARE), upregulating cytoprotective genes including NQO1 and HMOX1. It also reduces NF-κB-driven pro-inflammatory cytokine expression in macrophage models.
Systemic Signaling (Mitokine)
MOTS-C functions as a mitokine — circulating in plasma and acting on distant tissues. Plasma MOTS-C crosses biological barriers and has been detected in cerebrospinal fluid, suggesting potential CNS signaling roles that are actively being studied in neurometabolic research.
Proposed Mechanisms of Action
MOTS-C inhibits ATIC (AICAR transformylase / IMP cyclohydrolase) in the folate-methionine cycle, causing ZMP accumulation. ZMP mimics AMP and directly activates AMP-activated protein kinase (AMPK) by binding the regulatory γ-subunit — a mitochondria-to-cytoplasm metabolite signaling relay.
AMPK activation by MOTS-C/ZMP phosphorylates TBC1D1 and TBC1D4 (Akt substrate of 160 kDa, AS160), triggering GLUT4 vesicle exocytosis to the sarcolemma. This insulin-independent glucose uptake mechanism is particularly relevant to insulin resistance research models.
Under metabolic or oxidative stress, MOTS-C translocates from mitochondria to the nucleus via a heat shock protein-dependent transport mechanism. In the nucleus, it activates Nrf2/ARE targets including NQO1, HMOX1, and GCLC, enhancing antioxidant and cytoprotective gene expression.
MOTS-C upregulates PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), driving mitochondrial biogenesis, increased oxidative phosphorylation capacity, and upregulation of fatty acid β-oxidation enzymes. This metabolic reprogramming toward oxidative metabolism is a key longevity-relevant mechanism.
MOTS-C suppresses NF-κB nuclear translocation in macrophages and adipose tissue, reducing IL-6, TNF-α, and MCP-1 in aged mice. This anti-inflammatory activity intersects with AMPK signaling (AMPK phosphorylates IKKβ, blocking NF-κB) — relevant to inflammaging research.
Active Research Applications
Metabolic Disease Models
HFD/obesity mouse models studying AMPK-mediated glucose uptake, insulin sensitization, and adiposity reduction.
Exercise Biology
Skeletal muscle mitochondrial biogenesis, aerobic capacity, and oxidative metabolism studies in aged and sedentary models.
Aging & Longevity Research
Healthspan studies correlating circulating MOTS-C levels with metabolic flexibility, inflammation, and lifespan parameters.
Mitochondrial Signaling
Mechanistic studies of mtDNA-encoded peptide nuclear translocation, ATIC inhibition, and ZMP-mediated AMPK crosstalk.
Inflammaging Models
NF-κB, IL-6, and adipose tissue macrophage polarization studies in aged rodent models using MOTS-C as an intervention.
Drug Discovery Platform
MOTS-C as reference compound for developing small-molecule AMPK activators or ATIC inhibitors with improved bioavailability.
Protocol Notes for Researchers
Related Research Compounds
MOTS-C — Research Grade ≥99%
Research-grade purity ≥99% · Third-party HPLC verified · Ships from the U.S.
All products sold by Lumen Peppers are intended exclusively for in vitro laboratory research and investigative purposes. These compounds are not approved by the FDA for human or veterinary use. They are not drugs, supplements, or medications. Lumen Peppers makes no therapeutic claims. Researchers are solely responsible for ensuring compliance with all applicable laws and regulations in their jurisdiction.